Adcendo ApS
10 known investors
Find your way into Adcendo ApS
Sign up to see every warm intro you have to Adcendo ApS
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adcendo ApS team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
Investors · 10
How we know: Vida Ventures's portfolio page · Not right? Tell us
How we know: Novo Holdings's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
Related companies · 2
Companies working in the same space as Adcendo ApS.
Frequently asked questions
- What does Adcendo ApS do?
- Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
- Who are Adcendo ApS's investors?
- Adcendo ApS's investors include Vida Ventures, HealthCap, Jeito Capital, Novo Holdings, OrbiMed, Pontifax Venture Capital, RA Capital, TCG Crossover and 2 more.






